Axinn Serving as Patent Counsel for ADHD and Pain Relief Medications
May 1, 2007
Axinn represented Actavis Group in connection with its launch of multiple ADHD and pain relief medications. This representation included ongoing advice and counseling and current defense of patent litigation against generic versions of Ritalin LA®, Adderall XR® and Oxycontin.®
To subscribe to our publications, click here.
Featured Insights
Featured Insights
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
Navigating the Hart-Scott-Rodino Act in 2025
Webinar
Antitrust
French Competition Enforcement in the New EU Paradigm
Axinn Viewpoints
Antitrust
Is Antitrust Fashionable This Season? Antitrust in the Fashion Industry
Podcast
Antitrust
The Yellow Rose of Antitrust
Byline Articles
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
State by State, Pre-Merger Notifications Expand
Axinn Viewpoints
Antitrust
FTC claims diverging market from EU in Mars/Kellanova clearance
Media Mentions